Evidence map›Paper›PMID 28947496›Full record

ReviewGenes & development2017

Lymphangiogenesis guidance by paracrine and pericellular factors.

Kari Vaahtomeri, Sinem Karaman, Taija Mäkinen, Kari Alitalo

Open access · diamondAbstract readReview
In one paragraph

Review in Genes & development, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 97 papers.

0numbers the graph read from it
0cells of the map it votes in
97citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

97 citing papers in PubMed, 180 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Promising Adventitia in Atherosclerosis.Current vascular pharmacology · 2025
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Cellular and molecular mechanisms of skin wound healing.Nature reviews. Molecular cell biology · 2024
    Review
  20. Article

37 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Kari VaahtomeriWihuri Research Institute, Translational Cancer Biology Program, Biomedicum Helsinki, University of Helsinki, FI-00014 Helsinki, Finland.
Sinem KaramanWihuri Research Institute, Translational Cancer Biology Program, Biomedicum Helsinki, University of Helsinki, FI-00014 Helsinki, Finland.
Taija MäkinenDepartment of Immunology, Genetics, and Pathology, Uppsala University, 75185 Uppsala, Sweden.
Kari AlitaloWihuri Research Institute, Translational Cancer Biology Program, Biomedicum Helsinki, University of Helsinki, FI-00014 Helsinki, Finland.
Wihuri Research Institute · FIUniversity of Helsinki · FIUppsala University · SE

Funding

European Research Council 646849
6 · The paper itself

Abstract

Lymphatic vessels are important for tissue fluid homeostasis, lipid absorption, and immune cell trafficking and are involved in the pathogenesis of several human diseases. The mechanisms by which the lymphatic vasculature network is formed, remodeled, and adapted to physiological and pathological challenges are controlled by an intricate balance of growth factor and biomechanical cues. These transduce signals for the readjustment of gene expression and lymphatic endothelial migration, proliferation, and differentiation. In this review, we describe several of these cues and how they are integrated for the generation of functional lymphatic vessel networks.

Indexed as

LymphangiogenesisAnimalsBasement MembraneCarcinogenesisInflammationIntegrinsIntercellular Signaling Peptides and ProteinsLymphatic VesselsMiceParacrine CommunicationVascular Endothelial Growth Factor CVascular Endothelial Growth Factor Receptor-3IntegrinsIntercellular Signaling Peptides and ProteinsVascular Endothelial Growth Factor CVascular Endothelial Growth Factor Receptor-3interstitial fluid pressurelymphangiogenesislymphatic vessel basement membranelymphatic vessel sproutinglymphedemaVEGF-CVEGFR3

Identifiers

PMID28947496
PMCPMC5647933
OpenAlexW2757789394

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.